| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/14/2004 | CN1157366C Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active ingredients |
| 07/14/2004 | CN1157365C Monoamine reuptake inhibitors for treatment of CNS disorders |
| 07/14/2004 | CN1157224C Novel amide derives. as growth hormone secretagogues |
| 07/14/2004 | CN1157214C Pure Chinese medicine prepn for treating psychosis |
| 07/14/2004 | CN1157202C Application of cephalanoplos for antagonizing harmful substance of cigarette |
| 07/14/2004 | CN1157201C Composite non-opium medicine for dropping drugs |
| 07/14/2004 | CN1157197C Pharmaceutical for treating injury type vetebral injure |
| 07/14/2004 | CN1157186C Cholinergic agents in the treatment of presbyopia |
| 07/13/2004 | USRE38556 Recombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias |
| 07/13/2004 | US6762320 Monoamine oxidase b inhibitors; alzheimer's disease, senile dementia |
| 07/13/2004 | US6762308 Method for the preparation of citalopram |
| 07/13/2004 | US6762205 Phenyl sulfamate derivatives |
| 07/13/2004 | US6762200 Phospholipase inhibitors |
| 07/13/2004 | US6762196 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 07/13/2004 | US6762192 Useful in therapy and prophylaxis of epilepsy, migraine, and other disorders |
| 07/13/2004 | US6762191 Therapeutic compounds |
| 07/13/2004 | US6762186 Use to treat allergy, nasal congestion, inflammatory and central nervous system-related diseases |
| 07/13/2004 | US6762177 Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof |
| 07/13/2004 | US6762176 Inhibiting no-synthase enzymes producing nitrogen monoxide and/or trapping reactive forms of oxygen; inhibit lipidic peroxidation |
| 07/13/2004 | US6762165 Snail venom; muscular disorders, central nervous system disorders, cardiovascular disorders |
| 07/13/2004 | US6761910 Sublingually administering a drug with a bioadhesion or mucoadhesion promoting compound; water soluble carrier particles; effective plasma levels within a short time; fentanyl analgesic |
| 07/13/2004 | CA2348882C Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol |
| 07/13/2004 | CA2311356C Method for treating alzheimer's disease |
| 07/13/2004 | CA2268684C Process for alkylating hindered sulfonamides |
| 07/13/2004 | CA2255652C Isobutylgaba and its derivatives for the treatment of pain |
| 07/13/2004 | CA2118859C Enantiomers of 1-[(4-chlorophenyl)-phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine |
| 07/08/2004 | WO2004056827A2 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 07/08/2004 | WO2004056823A1 PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS |
| 07/08/2004 | WO2004056814A1 Oxazoles as mglur1 enhancer |
| 07/08/2004 | WO2004056800A1 Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/08/2004 | WO2004056799A2 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/08/2004 | WO2004056795A1 A process for preparing duloxetine and intermediates for use therein |
| 07/08/2004 | WO2004056791A1 Escitalopram hydrobromide and a method for the preparation thereof |
| 07/08/2004 | WO2004056774A2 Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators |
| 07/08/2004 | WO2004056772A1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as tachykinin antagonists |
| 07/08/2004 | WO2004056724A1 Deuterated catecholamine derivatives and medicaments comprising said compounds |
| 07/08/2004 | WO2004056376A1 Pharmaceutical formulations containing nitrate |
| 07/08/2004 | WO2004056369A1 Benzo ‘ d!azepine derivatives for the treatment of neurological disorders |
| 07/08/2004 | WO2004056368A1 Therapeutic applications of 2-substituted 4-heteroarylryrimidines |
| 07/08/2004 | WO2004056364A1 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/08/2004 | WO2004056324A2 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists |
| 07/08/2004 | WO2004056306A2 Use of l-dopa, derivatives thereof and medicaments comprising said compounds for the prophylaxis of psychotic diseases |
| 07/08/2004 | WO2004039835A3 Genes whose expression is increased in response to stimulation by corticotropin-releasing hormone |
| 07/08/2004 | WO2004039377A8 Use of piperazine sulfonic acid derivatives as ccr1 antagonists for the treatment of fibrosis, alzheimer disease and other disorders |
| 07/08/2004 | WO2004037791B1 Inhibitors of glycogen synthase kinase 3 |
| 07/08/2004 | WO2004037184A3 Methods for the treatment of skin disorders |
| 07/08/2004 | WO2004035779A8 Biomolecule transfer method using virus envelope and composition and system therefor |
| 07/08/2004 | WO2004028634A9 Method and composition for treating alzheimer's disease and dementias of vascular origin |
| 07/08/2004 | WO2004017920A3 Novel biphenyl and biphenyl-like cannabinoids |
| 07/08/2004 | WO2004014902A3 Compounds having an activity at metabotropic glutamate receptors |
| 07/08/2004 | WO2004004641A3 PKC ACTIVATION AS A MEANS FOR ENHANCING sAPPα SECRETION AND IMPROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS |
| 07/08/2004 | WO2003105771A3 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 07/08/2004 | WO2003103663A3 Substituted pyrrolines as kinase inhibitors |
| 07/08/2004 | WO2003070918A3 Rna interference by modified short interfering nucleic acid |
| 07/08/2004 | WO2003070192A3 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 07/08/2004 | WO2003066822A3 Truncated aggrecanase molecules |
| 07/08/2004 | WO2003058021A3 Novel apoptosis-inducing dna sequences |
| 07/08/2004 | WO2003039553B1 Compositions for treatment of postmenopausal female sexual dysfunction |
| 07/08/2004 | WO2003021225A3 Method for classification of anti-psychotic drugs |
| 07/08/2004 | WO2003002058A9 Bone anabolic compounds and methods of use |
| 07/08/2004 | WO2002097060A3 Carbohydrate-associated proteins |
| 07/08/2004 | US20040133933 Medane genes and proteins |
| 07/08/2004 | US20040133017 Reducing an unisolable magnesium salt of a benzophenone derivative to form 4-bromo-(2-hydroxymethyl)phenyl-(41-fluorophenyl)methanol, treating with acid catalyst; reacting with copper cyanide, isolation, recrystallization, reacting |
| 07/08/2004 | US20040133012 For use as anesthetics and as neuroprotective agents; prevents the formation of the toxic metabolite, 2-phenyl-acrylamide |
| 07/08/2004 | US20040132828 Polymorphic forms of sertraline hydrochloride |
| 07/08/2004 | US20040132824 Novel methods and compositions for alleviating pain |
| 07/08/2004 | US20040132822 Crystalline solid form of (2S,5Z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 07/08/2004 | US20040132809 Cell adhesion inhibitors |
| 07/08/2004 | US20040132808 precipitating the citalopram base in crystalline form, and transforming the base into a pharmaceutically acceptable citalopram salt; useful for removing intermediates which are structurally closely related to citalopram |
| 07/08/2004 | US20040132800 aminomethyl- or ethyl-substituted indoles, tetrahydrocarbazoles and tetrahydropyrido[1,2-a]indoles |
| 07/08/2004 | US20040132799 Aminoalkoxyindoles and methods of use |
| 07/08/2004 | US20040132797 treating of or preventing relapse of depression, anxiety disorders, eating disorders, or urinary incontinence |
| 07/08/2004 | US20040132794 Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 07/08/2004 | US20040132792 Oxazoles as mGluR 1 enhancers |
| 07/08/2004 | US20040132790 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof |
| 07/08/2004 | US20040132788 thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives; treating neurodegenerative disorders or pain. |
| 07/08/2004 | US20040132782 Aspartyl protease inhibitors |
| 07/08/2004 | US20040132781 Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2004 | US20040132780 Method and compositions for treating migraines |
| 07/08/2004 | US20040132757 Triazospiro compounds having nociceptin receptor affinity |
| 07/08/2004 | US20040132751 Use of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotrops |
| 07/08/2004 | US20040132741 N-sulfonylindoles and N-sulfonylindazoles; treating motor disorders, anxiety disorders or cognitive disorders, such as schizophrenia, depression, Alzheimer's disease or Parkinson's disease |
| 07/08/2004 | US20040132735 Beta-carboline derivatives and its pharmaceutical use aginst depression and anxiety |
| 07/08/2004 | US20040132734 Azaindoles having serotonin receptor affinity |
| 07/08/2004 | US20040132729 Inhibitors of p38 |
| 07/08/2004 | US20040132726 New compounds |
| 07/08/2004 | US20040132725 tyrphostin preparations enriched in certain geometric isomers; treating protein tyrosine kinase related disorders. especially with slow release formulations |
| 07/08/2004 | US20040132720 Antidepressants |
| 07/08/2004 | US20040132717 2-Oxo-piperidinyl-and 2-oxo-azepanyl alkanoic acid derivatives for the treatment of epilepsy and other neurological disorders |
| 07/08/2004 | US20040132710 Lactams as tachkinin antagonists |
| 07/08/2004 | US20040132694 6-Chloro-3-(3,4-dioxo-2-phenylamino-cyclobut-1-enylamino)-2-hydroxy-benzamide; psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease |
| 07/08/2004 | US20040132686 C2,5'- disubstituted and N6, c2,5'- trisubstituted adenosine derivatives and their different uses |
| 07/08/2004 | US20040132648 Remedies and/or preventives for conformational diseases |
| 07/08/2004 | US20040132641 Fas peptide mimetics and uses thereof |
| 07/08/2004 | US20040132636 Pharmaceutical uses for alpha2delta ligands |
| 07/08/2004 | US20040132163 Biological materials and uses thereof |
| 07/08/2004 | US20040132159 Novel beta-secretase and modulation of beta-secretase activity |
| 07/08/2004 | US20040132139 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders |
| 07/08/2004 | US20040132096 Method of identifying modulators of nogo-functions |
| 07/08/2004 | US20040132057 Tumor necrosis related receptor,TR7 |